Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of celecoxib in metastatic differentiated thyroid carcinoma.
Mrozek E, Kloos RT, Ringel MD, Kresty L, Snider P, Arbogast D, Kies M, Munden R, Busaidy N, Klein MJ, Sherman SI, Shah MH. Mrozek E, et al. Among authors: shah mh. J Clin Endocrinol Metab. 2006 Jun;91(6):2201-4. doi: 10.1210/jc.2005-2498. Epub 2006 Mar 7. J Clin Endocrinol Metab. 2006. PMID: 16522694 Clinical Trial.
Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma.
Woyach JA, Kloos RT, Ringel MD, Arbogast D, Collamore M, Zwiebel JA, Grever M, Villalona-Calero M, Shah MH. Woyach JA, et al. Among authors: shah mh. J Clin Endocrinol Metab. 2009 Jan;94(1):164-70. doi: 10.1210/jc.2008-1631. Epub 2008 Oct 14. J Clin Endocrinol Metab. 2009. PMID: 18854394 Free PMC article. Clinical Trial.
Phase II trial of sorafenib in metastatic thyroid cancer.
Kloos RT, Ringel MD, Knopp MV, Hall NC, King M, Stevens R, Liang J, Wakely PE Jr, Vasko VV, Saji M, Rittenberry J, Wei L, Arbogast D, Collamore M, Wright JJ, Grever M, Shah MH. Kloos RT, et al. Among authors: shah mh. J Clin Oncol. 2009 Apr 1;27(10):1675-84. doi: 10.1200/JCO.2008.18.2717. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255327 Free PMC article. Clinical Trial.
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Lam ET, Ringel MD, Kloos RT, Prior TW, Knopp MV, Liang J, Sammet S, Hall NC, Wakely PE Jr, Vasko VV, Saji M, Snyder PJ, Wei L, Arbogast D, Collamore M, Wright JJ, Moley JF, Villalona-Calero MA, Shah MH. Lam ET, et al. Among authors: shah mh. J Clin Oncol. 2010 May 10;28(14):2323-30. doi: 10.1200/JCO.2009.25.0068. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368568 Free PMC article. Clinical Trial.
Thyroid cancer: emerging role for targeted therapies.
Sipos JA, Shah MH. Sipos JA, et al. Among authors: shah mh. Ther Adv Med Oncol. 2010 Jan;2(1):3-16. doi: 10.1177/1758834009352667. Ther Adv Med Oncol. 2010. PMID: 21789122 Free PMC article.
Role of BRAF in thyroid oncogenesis.
Caronia LM, Phay JE, Shah MH. Caronia LM, et al. Among authors: shah mh. Clin Cancer Res. 2011 Dec 15;17(24):7511-7. doi: 10.1158/1078-0432.CCR-11-1155. Epub 2011 Sep 7. Clin Cancer Res. 2011. PMID: 21900390 Review.
347 results